This chemical is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structural features, including the morpholine ring and reactive functional groups, make it valuable in the development of drugs targeting neurological disorders, particularly those involving dopamine receptors. It is also employed in the production of chiral compounds, where its stereochemistry plays a crucial role in enhancing the efficacy and selectivity of therapeutic agents. Additionally, it finds use in research and development for creating novel compounds with potential applications in treating metabolic and cardiovascular diseases.